Abstract
A plethora of recent evidence suggests that some kind of oxidative process is involved in atherogenesis and that the oxidation of low density lipoprotein (LDL) may play a significant pathogenic role in atherosclerosis [1–3]. Based on the recommendations of the National Heart, Lung, and Blood Institute’s expert panel [4], clinical trials to test the validity of the hypothesis in man are being undertaken using combinations of natural antioxidants.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Steinberg D, Parthasarathy S, Carew, TE, Khoo, JC, Witztum JL. Beyond Cholesterol. Modifications of low density lipoprotein that incresae its atherogenicity. N. Engl. J. Med. 320: 915–924 (1989).
Parthasarathy S, Steinberg D, Witztum,J.L. Annu. Rev. Med. 43: 219 225 (1992).
Parthasarathy, S and Rankin, S.M. Role of oxidized low density lipoprotein in atherogenesis. Progr. Lipid Res. 31: 127–143 (1992).
Steinberg D, Workshop Participants: Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung and Blood Institute workshop. Circulation 85: 2337–2344 (1992).
Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation and slow the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84: 7725–7729 (1987).
Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84: 5928–5931 (1987).
Mao, S.J.T., Yates, M.T., Parker, R.A., Chi, E.M., and Jackson, R.L. Attenuation of atherosclerosis in a modified strain if hypercholesterolemic watanabe rabbit with use of a probucol analog (MDL 29, 311) that does not lower serum cholesterol. Arterios. Thromb. 11: 1266–1275 (1991).
Björkhem, I., Henriksson-Freyschuss, A., Breuer, O., Diczfalusy, U., Berglund, L., and Henriksson, P. The antioxidant butylated hydroxytoluene protects against atherosclerosisArterios. Thromb. 11: 15–22 (1991).
Sparrow, C.P., Doebber, T.W., Olszwski, J., Wu, M.S., Ventre, J., Stevens, K.A. and Chao, Y. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbit by the antioxidant N,N’diphenyphenylenediamine. J. Clin. Invest. 89: 1885–1891 (1992).
Verlangieri, A.J. and Bush, M.J. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. Am. Coll. Nutr. 11: 131–138 (1992).
Daugherty, A., Zweifel, B.S. and Schenfeld, G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Brit. J. Pharmacol. 103: 1013–1018 (1989).
Gey, K.F. and Puska, P. Plasma vitamin E and A inversely related to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. Ny Acad. Sci. 570, 254–282 (1989)
Esterbauer, H., Schaur, R.J. and Zollner, H. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free. Radic. Biol. Med. 11: 81–128 (1992).
Hansson, G.K. Seifert-P-S. Olsson-G. Bondjers-G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesion of cholesterol-fed rabbits. Arterioscler-Thromb. 11: 745–750 (1991).
Gerrity, R.G., Naito, H.K., Richardson, M. and Schwartz, C.J. Dietary induced atherogenesis in swine. Am. J. Pathol. 95: 775–792 (1979).
Steinbrecher.U. P, Witztum. J. L, Parthasarathy. S and Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 7: 135–143 (1987).
Steinbrecher, U.P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603–3608 (1987).
Steinbrecher U.P, Parthasarathy S, Leake D.S, Witztum J.L and Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low densityl lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81: 3883–3887 (1984).
Parthasarathy, S., Steinbrecher, U.P., Barnett, J., Witztum, J.L. and Steinberg, D. Essential role of phospholipase A2 in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. acad. Sci. USA. 82, 3000–3004 (1985).
Parthasarathy, S. and Barnett, J. Phospholipase A2 activity of low density lipoprotein: Evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc. Natl. Acad. Sci. USA. 87, 9741–9745 (1990).
Stafforini, D.M., McIntyre, T.M., Carter, M. E. and Prescott, S.M. Human plasma platelet-activating factor hydrolase. Association with lipoprotein particles and role in the degradation of platelet activating factor. J. Biol. Chem. 262, 4215–4222 (1987).
Stremler, K.E., Stafforini, D.M., Prescott, S.M., Zimmerman, G.A and McIntyre, T.M. An oxidized derivative of phosphatidylcholine is a substrate for the platelet activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264, 5331–5334 (1989).
Steinbrecher, U.P. and Pritchard, H.P. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet activating factor acetyl hydrolase. J. Lipid Res. 30, 305–315 (1989).
Stafforini, D.M., Carter, M.E., Zimmerman, G.A., McIntyre, T.M. and Prescott, S.M. Lipoproteins alter the catalytic behaviour of the platelet activating factor acetylhydrolase in human plasma. Proc. Natl. Acad. Sci. USA 86, 2393–2397 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Parthasarathy, S., Barnett, J. (1994). Phospholipase Action in the Generation of Modified LDL. In: Mackness, M.I., Clerc, M. (eds) Esterases, Lipases, and Phospholipases. NATO ASI Series, vol 266. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0993-0_29
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0993-0_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0995-4
Online ISBN: 978-1-4899-0993-0
eBook Packages: Springer Book Archive